1
TITLE: Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naive patients: results of the EPIC study (CCR100136)  Full Text
AUTHORS: Yeni, P; LaMarca, A; Berger, D; Cimoch, P; Lazzarin, A; Salvato, P; Smaill, FM; Teofilo, E; Madison, SJ; Nichols, WG; Adkison, KK; Bonny, T; Millard, J; McCarty, D;
PUBLISHED: 2009, SOURCE: HIV MEDICINE, VOLUME: 10, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef